Clinical trial
Sulforaphane Treatment of Children With Autism Spectrum Disorder (ASD)
NCT02561481 is registered in ClinicalTrials.gov with University of Massachusetts, Worcester as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sulforaphane Treatment of Children With Autism Spectrum Disorder (ASD)
- Lead sponsor
- University of Massachusetts, Worcester
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- December 31, 2015
- Completion date
- January 31, 2020
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.